Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cephalon Inc.

Division of Teva Pharmaceutical Industries Ltd.

Latest From KuDOS Pharmaceuticals Ltd.

Making The Most Of A Maturing Myriad Genetics

Five and a half years after its decision to spin off its pharmaceutical business and a year and a half away from having the US Supreme Court break its monopoly on BRCA gene testing, Myriad Genetics is no longer an exception among molecular diagnostics companies. It must find its way along a more crowded path.

Medical Device BioPharmaceutical

Singapore’s MerLion Completes Phase III Finafloxacin Studies For Outer Ear Infection, Looks Ahead To Other Indications

Singapore-based MerLIon Pharmaceuticals has reached another milestone with its finafloxacin antibiotic with the topic form for outer ear infection successfully passing Phase III trials in North America. But the firm is still looking for help taking another indication into Phase III.

BioPharmaceutical Singapore

By Licensing Merck Drug, AstraZeneca Echoes Importance Of DNA Damage Response

By licensing MK-1775 from Merck, AstraZeneca underscores the key strategic role DNA damage response will play in the U.K. drug maker’s attempts to build oncology into a growth engine.

BioPharmaceutical United Kingdom

Financings Of The Fortnight Sees New Biotech Funding All Over The Globe, And Without Much VC Participation

Plus news on recent financial activity by Merrimack, Promethera, ADC Therapeutics and Enterome Bioscience.

BioPharmaceutical United States
See All

Company Information